Aequus Pharmaceuticals Stock Price History
AQS Stock | CAD 0.01 0.00 0.00% |
Below is the normalized historical share price chart for Aequus Pharmaceuticals extending back to March 17, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aequus Pharmaceuticals stands at 0.01, as last reported on the 1st of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day.
If you're considering investing in Aequus Stock, it is important to understand the factors that can impact its price. Aequus Pharmaceuticals is out of control given 3 months investment horizon. Aequus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate twenty-five different technical indicators, which can help you to evaluate if expected returns of 2.86% are justified by taking the suggested risk. Use Aequus Pharmaceuticals Downside Deviation of 43.96, risk adjusted performance of 0.0774, and Mean Deviation of 13.14 to evaluate company specific risk that cannot be diversified away.
At this time, Aequus Pharmaceuticals' Sale Purchase Of Stock is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to climb to 0.29 in 2024, despite the fact that Total Stockholder Equity is likely to grow to (4.1 M). . Price Earnings To Growth Ratio is likely to climb to 0.16 in 2024, whereas Price To Sales Ratio is likely to drop 10.77 in 2024. Aequus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.018 | 50 Day MA 0.0112 | Beta (0.01) |
Aequus |
Sharpe Ratio = 0.1062
Best Portfolio | Best Equity | |||
Good Returns | AQS | |||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
26.91 actual daily | 96 96% of assets are less volatile |
Expected Return
2.86 actual daily | 57 57% of assets have lower returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Aequus Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aequus Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 24.3946 | Enterprise Value Ebitda (2.19) | Price Sales 3.2102 | Shares Float 112.8 M | Wall Street Target Price 2.52 |
Aequus Pharmaceuticals Stock Price History Chart
There are several ways to analyze Aequus Stock price data. The simplest method is using a basic Aequus candlestick price chart, which shows Aequus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 5, 2024 | 0.015 |
Lowest Price | November 12, 2024 | 0.005 |
Aequus Pharmaceuticals December 1, 2024 Stock Price Synopsis
Various analyses of Aequus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aequus Stock. It can be used to describe the percentage change in the price of Aequus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aequus Stock.Aequus Pharmaceuticals Price Rate Of Daily Change | 1.00 |
Aequus Pharmaceuticals December 1, 2024 Stock Price Analysis
Aequus Stock Price History Data
The price series of Aequus Pharmaceuticals for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.02 with a coefficient of variation of 28.7. The prices are distributed with arithmetic mean of 0.01. The median price for the last 90 days is 0.01.Open | High | Low | Close | Volume | ||
12/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | ||
11/28/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,000 | |
11/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 6,000 | |
11/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 50,000 | |
11/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,190 | |
11/22/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 13,416 | |
11/21/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 408,000 | |
11/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 63,000 | |
11/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 37,037 | |
11/15/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,000 | |
11/14/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,000 | |
11/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/12/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 20,000 | |
11/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 22,905 | |
11/08/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/07/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 45,863 | |
11/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 144,000 | |
11/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 702,393 | |
11/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/31/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,000 | |
10/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/29/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/28/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 29,000 | |
10/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/23/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/22/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/21/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/17/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/16/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/15/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 9,706 | |
10/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 22,000 | |
10/10/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 12,000 | |
10/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 4,000 | |
10/08/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/07/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 11,012 | |
10/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 20,000 | |
10/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 6,000 | |
10/02/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
10/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,000 | |
09/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 5,000 | |
09/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/23/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 205,000 | |
09/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/17/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 11,224 | |
09/16/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/12/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/10/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 64,000 | |
09/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 100,000 | |
09/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
09/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 |
About Aequus Pharmaceuticals Stock history
Aequus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aequus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aequus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aequus Pharmaceuticals stock prices may prove useful in developing a viable investing in Aequus Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 152.5 M | 83.9 M | |
Net Loss | -2.1 M | -2.2 M |
Aequus Pharmaceuticals Stock Technical Analysis
Aequus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Aequus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aequus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aequus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aequus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0774 | |||
Jensen Alpha | 1.74 | |||
Total Risk Alpha | (2.09) | |||
Sortino Ratio | 0.0503 | |||
Treynor Ratio | 0.4993 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.